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ABSTRACT 
Background: The tauGFP reporter fusion protein is produced nearly ubiquitously by the TgTP6.3 
transgene in TP6.3 mice and its localisation to microtubules offers some advantages over soluble 
GFP as a lineage marker. However, TgTP6.3Tg/Tg homozygotes are not viable and TgTP6.3Tg/- 
hemizygotes are smaller than wild-type. TP6.4 mice carry the TgTP6.4 transgene, which was 
produced with the same construct used to generate TgTP6.3, so we investigated whether TgTP6.4 
had any advantages over TgTP6.3.  
Results: Although TgTP6.4Tg/Tg homozygotes died before weaning, TgTP6.4Tg/- hemizygotes were 
viable and fertile and only males were significantly lighter than wild-type. The TgTP6.4 transgene 
produced the tauGFP fusion protein by the 2-cell stage and it was widely expressed in adults but 
tauGFP fluorescence was weak or absent in several tissues, including some neural tissues. The 
TgTP6.4 transgene expression pattern changed over several years of breeding and mosaic transgene 
expression became increasingly common in all expressing tissues. This mosaicism was used to 
visualise clonal lineages in the adrenal cortex of TgTP6.4Tg/- hemizygotes and these were 
qualitatively and quantitatively comparable to lineages reported previously for other mosaic 
transgenic mice, X-inactivation mosaics and chimaeras. Mosaicism occurred less frequently in 
TP6.3 than TP6.4 mice and was only observed in the corneal epithelium and adrenal cortex.  
Conclusions: Mosaic expression makes the TgTP6.4 transgene unsuitable for use as a conventional 
cell lineage marker but such mosaicism provides a useful system for visualising clonal lineages that 
arise during development or maintenance of adult tissues. Differences in the occurrence of 
mosaicism between related transgenic lines, such as that described for lines TP6.3 and TP6.4, might 
provide a useful system for investigating the mechanism of transgene silencing. 
KEY WORDS 
mosaic transgene expression; green fluorescent protein; tauGFP; adrenal cortex lineages; 
preimplantation embryo; time-lapse imaging  
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BACKGROUND 
Two lines of transgenic mice, TP6.3 and TP6.4, express CAG-tauGFP transgenes TgTP6.3 and 
TgTP6.4 respectively [1]. Both lines TP6.3 and TP6.4 were produced by electroporation of the 
same construct into embryonic stem (ES) cells, which were then used to generate ES cell chimaeras 
and founder transgenic mice. Line TP6.3 expresses a tau-green fluorescent protein (tauGFP) fusion 
protein almost ubiquitously. Its localisation to microtubules has some advantages over soluble GFP 
as a lineage marker and it is well suited for labelling axons, blood vessels and preimplantation 
embryos [1, 2]. This TgTP6.3 tauGFP marker has been used to identify cell fusion between ES cells 
and other cell types [3] and as a lineage marker for macrophages [4], ovarian cells [5], 
preimplantation embryos [6] and, in particular, neural tissues [7-12].  
TgTP6.4 transgene expression was reported to be strong in many tissues yet only weak in much of 
the central nervous system but it was not fully characterised [1]. As TgTP6.3Tg/Tg homozygotes are 
lethal and TgTP6.3Tg/- hemizygotes are smaller than wild-type (WT) siblings we evaluated the 
second tauGFP transgenic line to determine whether TgTP6.4 had any advantages over the TgTP6.3 
marker transgene. We investigated growth of TgTP6.4Tg/- hemizygotes and the viability of 
TgTP6.4Tg/Tg homozygotes and we characterised expression of the TgTP6.4 transgene in embryos 
and adults by confocal microscopy of tauGFP fluorescence. This revealed that TgTP6.4Tg/- mice 
showed widespread mosaic expression. As mosaicism can be useful for analysis of clonal lineages 
that are established during development or by adult stem cells, we also compared mosaic expression 
in the adrenal cortices of TgTP6.3Tg/- and TgTP6.4Tg/- hemizygotes. 
METHODS 
Mice  
C57BL/6 and outbred CD-1 mice were purchased from Bantin and Kingman, Hull, UK and 
A/J/Ola/Hsd mice were purchased from Harlan Olac Ltd, Bicester, UK. BALB/c/Eumm, CBA/Ca, 
C57BL/OlaWs (a C57BL/OlaHsd sub-colony), (C57BL × CBA/Ca)F1 hybrids, TP6.3 and TP6.4 
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mice were bred and maintained under conventional conditions at the University of Edinburgh with a 
light cycle of 14 hours light (05:00 h. - 19:00 h.) and 10 hours dark or 12 hours light (06:00 h. - 
18:00 h.) and 12 hours dark. Founder TP6.3 and TP6.4 mice were produced from chimaeras made 
with E14Tg2a ES cells that had been transfected with the CAG-tauGFP vector, pTP6 [1, 2]. 
Founder mice were on a largely outbred MF1 genetic background and the transgenes were bred 
onto other strains as required. Transgenic mice were maintained by crossing TgTP6.3Tg/- and 
TgTP6.4Tg/- hemizygotes to non-transgenic, wild-type (WT) mice. Both TP6.3 and TP6.4 mice were 
initially crossed to inbred C57BL/6 mice to produce the first colony of each transgenic line, and 
some mice were also crossed to outbred, albino CD-1 mice to facilitate confocal microscopy of 
tauGFP expression in eye tissues. These colony I mice were used for the initial investigations 
shown in Fig. 3 and Additional file 1: Table S1. For later studies, TgTP6.3Tg/- and TgTP6.4Tg/- mice 
from the first colonies were crossed to (C57BL × CBA/Ca)F1 hybrid mice to produce a second 
colony for each line. These colony II mice were maintained by crossing transgenic mice to (C57BL 
× CBA/Ca)F1 mice at each generation and were used for the investigations shown in Figs. 1, 2, 4, 5, 
Additional file 1: Figs. S2, S3 and S4 and Table 1. In all genetic crosses the female parental 
genotype is shown first. TauGFP-positive offspring were identified at weaning by the green 
fluorescence of their ear punch biopsies, using a fluorescence microscope with a fluorescein 
isothiocyanate (FITC) filter set. Some tauGFP-positive newborn pups were identified as described 
elsewhere [13].  
Analysis of postnatal growth 
Newborn pups from crosses between (C57BL × CBA/Ca)F1 females and hemizygous TgTP6.4Tg/- 
males were sexed and weighed on postnatal days (P) 1 and 7 and then at weekly intervals thereafter 
until P84. Individual pups were marked with a marker pen until they were old enough for an ear 
punch biopsy, which was used both for identification and classification of their tauGFP phenotype.  
Analysis of preimplantation embryos 
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For collection of preimplantation embryos, females were superovulated by intraperitoneal (i.p.) 
injections of 5 international units (I.U.) of pregnant mare’s serum gonadotrophin (PMSG; Folligon, 
Intervet) at approximately 12 noon followed 48 hours later by 5 I.U. of human chorionic 
gonadotrophin (hCG; Chorulon, Intervet). After hCG injections, each female was caged with a male 
overnight and mating was verified by the presence of a vaginal copulation plug the following 
morning, which was designated embryonic day (E) 0.5. Preimplantation embryos were flushed from 
the reproductive tract with KSOM-H handling medium [14] and their ages in hours post coitum 
(p.c.) were timed from the mid-point of the dark period (midnight) following the hCG injection. For 
collection of 1-cell stage embryos, mice were killed at approximately 10:00 h. on the morning after 
the hCG injection, cumulus masses were released from the oviducts and cumulus cells were 
dispersed in a solution of 100 I.U. hyaluronidase (Sigma-Aldrich, Gillingham, UK) per ml of 
phosphate-buffered saline (PBS). Two cell-stage embryos were flushed from the oviducts at 
approximately 10:00 h. on the following day (34 h.). 
For time-lapse monitoring, preimplantation embryos were cultured for 24 hours in drops of KSOM 
culture medium under mineral oil in thin glass-bottomed dishes (WillCo HBSt 3522, Intracel Ltd. 
Royston, UK). The dishes were placed in an environmental chamber on top of the heated stage 
(THD 60, Linkam Scientific Instruments Ltd, Tadworth, UK) of an inverted Leica DMIRB/E 
confocal microscope, and the atmosphere within the chamber was maintained at 37oC, 5% CO2 in 
air (Additional file 1: Fig. S1). Images were acquired every 15 or 30 minutes for approximately 24 
h. in both fluorescent (FITC) and transmitted light mode, using the Leica TCS NT confocal system. 
The time-lapse files contained both FITC and transmitted light channels from each time point. 
These were merged to provide photographs showing GFP fluorescence overlaid on a transmitted 
light image for the figures. Each image from the FITC channel is a pseudocoloured greyscale 
representation of the intensity of the emission signal from the sample, rendered on a 0-255 pixel 
intensity scale, which represents the strength of fluorescence. For quantitative analysis, files for 
each time point were opened in the freeware image analysis program, Scion Image 
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(http://downloads.informer.com/scion-image/) each embryo was outlined as a region of interest 
(ROI) and an average pixel intensity reading obtained. If embryos moved between frames (time 
points), the ROI was either moved or redrawn for analysis of the next frame. Embryos that were 
cultured from the 2-cell stage but failed to cleave were excluded from the analysis. The embryos 
sometimes drifted out of focus so, typically, a short (1-2 h.) culture period was recorded at the 
beginning of the experiment and examined, so the focus could be adjusted if required. The focus 
was also checked prior to overnight recording. These interruptions meant that each time-lapse 
experiment comprised several separate files, which sometimes differed slightly in pixel intensity 
because of fluctuations in laser power that occurred while scanning was interrupted. 
Analysis of transgenic fetuses 
Fetuses were produced by natural matings and staged from the date of the copulation plug, as 
described above. Females were killed by cervical dislocation, and the numbers of implantation sites, 
moles (resorbing conceptuses), dead fetuses and live fetuses were noted. Conceptuses were 
removed from the uterus and the fetuses dissected free of their placentas and extraembryonic 
membranes with fine forceps. Fetuses were classified for tauGFP expression with a Leica M2FLIII, 
fluorescence dissecting microscope using a GFP filter set. For comparison of fetal sizes, E14.5 
fetuses were blotted dry, weighed and their crown-rump lengths were measured.  
Analysis of tauGFP expression in tissue sections from fetal and adult transgenic mice 
Hemizygous adults and E13.5 and E17.5 fetuses were produced as described above. Fetuses were 
decapitated and fixed in ice cold 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) 
overnight at 4oC. Some small tissue samples from adults were also fixed by this immersion method. 
Other adult samples were perfusion fixed, while the mouse was deeply anaesthetised with a 0.4 ml 
i.p. injection of 25% urethane in saline. The vascular system was then flushed with ice-cold 0.9% 
saline via cardiac puncture, followed by perfusion with ice-cold 4% PFA in PBS. After perfusion, 
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the mouse was killed and various organs, including brain, heart, liver, kidney and eyes, were 
removed and fixed overnight in fresh ice-cold 4% PFA in PBS. 
Fixed samples were washed in two changes of PBS and embedded in 4% agarose (LMP Agarose, 
Bethesda Research Laboratories, Life Tech inc., USA). Blocks were trimmed, mounted on glass 
with adhesive and 200 µm sections were cut with a vibratome. Prior to mounting, some vibratome 
tissue sections were counterstained with propidium iodide (PI) solution (0.1% PI, 0.05% RNase, 
0.1% Triton X-100 in PBS) for 5 minutes then rinsed in PBS, to label nuclear DNA fluorescent red. 
In some cases RNase was omitted, so cytoplasmic RNA was also counterstained. Sections were 
washed in PBS, immersed in a mixture of glycerol and PBS (1:1 v/v) at 4°C until saturated and 
mounted on glass slides in a 1:1 mixture of glycerol and PBS containing 1% Vectashield antifade 
reagent (H-100, Vector Labs Inc, USA). The coverslips were sealed with Aquamount. Sections 
were viewed with an upright Leica TCS NT confocal microscope (Leica Microsystems, Germany). 
Bright-field images were collected in the transmitted light channel and GFP was detected in the 
FITC channel. For sections that were counterstained with propidium iodide, optical sections were 
acquired simultaneously in the FITC (green) and tetramethylrhodamine isothiocyanate (TRITC; 
red) channels. Single optical sections and stacks of sections were acquired with a minimum of 4 
averages per optical section. 
Analysis of tauGFP expression by fluorescence activated cell sorting 
TauGFP-positive and negative E14.5 fetuses, from crosses to outbred CD-1 strain mice, were 
dissected in ice-cold Earle’s Balanced Salt Solution (EBSS), pre-equilibrated in 5% CO2. Whole 
brains, hippocampus, cerebral cortex, ventral telencephalon, central and dorsal thalamus, and 
midbrain and hindbrain tissues were dissected and dissociated using the Worthington Papain 
Dissociation System, (Worthington Biochemical Corporation, USA). Dissociated cells were sorted 
for green fluorescence using a Fluorescence Activated Cell Sorter (FACS; Becton Dickinson, 
Rutherford, NJ, USA) to generate histograms of green fluorescence intensity (FL1 channel) versus 
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cell number for 10,000 cells per sample. Gates identifying cell populations with different 
fluorescent intensities were defined using a tauGFP-positive TP6.3 brain sample, considered to 
contain 100% fluorescent cells and the same gates were applied to all samples. After gating to 
exclude outliers (predominantly dead cells), the percentage of cells in three gated regions, 
corresponding to different fluorescent intensities, were compared: region M1 included all 
fluorescent cells, M2 included cells with low fluorescence and M3 included cells with high 
fluorescence. 
Analysis of mosaicism in adrenal glands 
In TgTP6.4Tg/- and many TgTP6.3Tg/- hemizygous mice, the adrenal cortex was not uniformly 
tauGFP-positive but, in sections, showed a radial pattern of tauGFP-positive and tauGFP-negative 
stripes, most of which extended continuously across the full width of the adrenal cortex. This 2-
dimensional radial stripe pattern in sections was analysed as a 1-dimensional pattern of stripe 
widths by measuring around the adrenocortical circumference as described previously [15]. The 
width of each tauGFP-negative and tauGFP-positive stripe was measured in calibrated images of 
single sections near the middle of the adrenal gland using UTHSCSA Image Tool software for 
Microsoft Windows (http://compdent.uthscsa.edu/dig/itdesc.html). Measurements were made 
around the complete circumference of the adrenal cortex at a similar distance from the outer edge of 
the adrenal gland (equivalent to 20% of the distance from the capsule to the inner margin of cortex). 
This provided the numbers of tauGFP-negative and tauGFP-positive stripes, the observed mean 
stripe widths, the total measured circumference and the proportions of tauGFP-negative and 
tauGFP-positive cells at the depth of the measurements for each adrenal cortex analysed. To allow 
for differences in stripe widths at different radial positions, the stripe width was expressed as a 
proportion of the circumference. 
The radial stripes are believed to represent coherent clones of cells derived from stem cells at the 
periphery of the adrenal cortex [15, 16]. However, it is misleading to compare observed stripe 
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numbers directly because each stripe may comprise several adjacent coherent clones and the 
number of clones per stripe is likely to vary according to the proportions of tauGFP-positive and 
tauGFP-negative cells in the tissue. We, therefore, converted the observed number of tauGFP-
positive stripes plus tauGFP-negative stripes to a ‘corrected stripe number’ for each section, which 
adjusts for the expected number of clones per stripe [15]. First, the observed mean tauGFP-negative 
stripe width was divided by the correction factor 1/(1-p), where p is the proportion of tauGFP-
negative cells around the circumference [15, 17, 18]. As the radial stripes in sections of the adrenal 
cortex form a complete circle, the calculated ‘corrected mean stripe width’ will be the same for both 
the positive and negative stripes, as explained previously [15, 17, 18]. Thus, correction of mean 
tauGFP-positive stripe widths, using the proportion of tauGFP-positive cells as p, produced 
identical results. As the ‘corrected mean stripe width’ applies to both tauGFP-negative and tauGFP-
positive stripes, the ‘corrected stripe number’ for the positive plus negative stripes is the reciprocal 
of the corrected mean stripe width, expressed as the proportion of the measured circumference. The 
calculated corrected stripe number adjusts for differences in proportions of tauGFP-positive cells 
among adrenals and is likely to be proportional to the number of active coherent clones of stem 
cells, so was used to compare different groups of adrenal glands as described elsewhere [15]. 
Statistics 
Minimum group sizes were guided by previous experience and power calculations. For comparison 
of postnatal growth, TP6.4 group sizes were chosen to ensure sufficient power to detect, as 
significant (P < 0.05), mean body mass differences that were smaller than those previously 
published for TP6.3 [1, 2]. For quantitative analysis of adrenal mosaicism, results for only one 
adrenal gland per mouse were included. For mice where both adrenal glands were imaged, the 
choice of including the left or right adrenal was randomised by tossing a coin. The choice of 
parametric or non-parametric tests was guided, in part, by normality tests. GraphPad Prism versions 
5.0c and 7 (GraphPad Software Inc., La Jolla, CA) were used for most statistical tests including 2-
way analysis of variance (ANOVA) followed by Bonferroni multiple comparison post-tests, 
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repeated measures 2-way ANOVA followed by Bonferroni multiple comparison post-tests, 1-way 
ANOVA, the paired t-test, the Mann-Whitney U-test and the Kruskal-Wallis test followed by 
Dunn’s multiple comparison post-tests. An online statistical calculator 
(http://vassarstats.net/index.html) was used for the chi-square goodness of fit test and Fisher’s exact 
test. Error bars shown are 95% confidence intervals (CI). 
RESULTS 
Postnatal growth and viability of hemizygous TgTP6.4Tg/- transgenic mice 
Fig. 1a,b shows postnatal growth curves, for offspring from crosses between (C57BL × CBA/Ca)F1 
females and hemizygous, TgTP6.4Tg/- males. The hemizygous males were themselves produced 
from crosses with (C57BL × CBA/Ca)F1 mice, so at least 75% of the genetic background of the 
weighed offspring was from the C57BL and CBA/Ca strains. Results showed that tauGFP-positive 
male offspring were significantly lighter than tauGFP-negative males from postnatal day (P) 28 but 
that tauGFP-positive females grew normally. Nevertheless, growth was less severely affected in 
tauGFP-positive, TP6.4 males than in tauGFP-positive, TP6.3 males or females. For comparison, 
previously published results for TP6.3 mice [2] are shown in Fig. 1c,d. Four mice from the TP6.4 
cross died before the end of the growth experiment but postnatal deaths were not more common 
among tauGFP-positive offspring. The surviving mice comprised 45 tauGFP-negative females, 50 
tauGFP-positive females, 61 tauGFP-negative males and 47 tauGFP-positive males (Fig. 1a,b). This 
frequency distribution did not differ from the expected 1:1:1:1 ratio (P = 0.3901 by goodness of fit 
chi-square test) and the overall frequency of tauGFP-positive mice (97/203 = 47.8%) was not 
significantly different from 50% (P = 0.5716), implying that viability of TgTP6.4Tg/- hemizygotes 
from this cross was normal. These crosses also provide evidence that the TgTP6.4 insertion site is 
not on the X-chromosome (unless it is in the pseudoautosomal region) because tauGFP-positive 
males transmitted the transgene approximately equally to their sons and daughters.  
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Viability of TgTP6.4Tg/Tg homozygotes 
We were unable to identify any adult TgTP6.4Tg/Tg homozygotes by overt differences in GFP 
fluorescence and, as the TgTP6.4 insertion site is unknown, we had no simple PCR method for 
distinguishing TgTP6.4Tg/Tg homozygotes from TgTP6.4Tg/- hemizygotes. In the absence of an easy 
method for identifying homozygotes, we used a statistical analysis of offspring phenotype 
frequencies from a genetic test cross to determine whether homozygotes were viable. Thirty-nine 
tauGFP-positive progeny, from TgTP6.4Tg/- × TgTP6.4Tg/- crosses, were crossed to non-transgenic 
mice to determine whether any only produced tauGFP-positive offspring and so were likely to be 
homozygotes. Thirty-six mice were classified as hemizygotes because they produced both tauGFP-
positive and tauGFP-negative offspring in either their first viable litter (35 cases) or their second 
litter (one case). One other mouse produced three litters with 9/9, 7/8 and 9/12 tauGFP-positive 
offspring, respectively. As the overall frequency (25/29) was significantly higher than the expected 
50% tauGFP-positive offspring (P = 0.0002), this mouse might have been a germline 
homozygous/hemizygous mosaic, rather than a hemizygote but it died before further investigations 
could be performed. Five of the other 36 mice produced equal numbers of tauGFP-positive and 
tauGFP-negative offspring, 16 produced more tauGFP-positive and 15 produced more tauGFP-
negative offspring. As the 16:15 ratio did not differ significantly from the 1:1 ratio expected if all 
36 mice were TgTP6.4Tg/- hemizygotes (P = 1.0000), there was no evidence that any of these were 
homozygous/hemizygous mosaics. This is also supported by the overall frequency of tauGFP-
positive offspring from these 36 mice (177/345; 51.3%), which was not significantly different from 
the expected 50% (P = 0.6714) for hemizygotes. The remaining two males failed to sire any 
offspring in three-months and we cannot exclude the possibility that these were infertile 
homozygotes. One third of the tauGFP-positive offspring from TgTP6.4Tg/- × TgTP6.4Tg/- crosses 
are expected to be homozygous but none of 37 fertile offspring bred as homozygotes. The 
probability of this occurring by chance is only (2/3)37 (P = 0.0000003), if homozygotes are actually 
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viable and fertile. These results imply that homozygous TgTP6.4Tg/Tg mice do not survive to 
reproduce. 
Further statistical evidence that homozygotes do not survive to adulthood was obtained 
retrospectively from our mouse colony breeding records for three crosses. Offspring were classified 
as tauGFP-positive or tauGFP-negative by fluorescence microscopy of ear tissue biopsied, when 
they were weaned at about three weeks (Table 1). As the maternal genotype has the potential to 
affect embryonic development, cross 2 (TgTP6.4Tg/- female × WT, TgTP6.4-/- male) is the most 
appropriate control for the experimental cross (TgTP6.4Tg/- × TgTP6.4Tg/-). The percentage of 
tauGFP-positive mice in this control cross (43.5%) did not differ significantly from the expected 
50% but it was significantly lower in the reciprocal cross (39.3%; see Table 1 for statistical 
analysis). This was unexpected, as the equivalent WT, TgTP6.4-/- female × TgTP6.4Tg/- male cross 
produced 47.8% tauGFP-positive mice for the growth curve experiment (Fig. 1). However, the 
retrospective breeding data were collected after the growth experiment was completed and records 
of later generations showed that many tauGFP-positive offspring had a mosaic tauGFP phenotype. 
Consequently, the tauGFP-positive frequency might have been underestimated if some TgTP6.4Tg/- 
offspring, with mosaic transgene expression, were misclassified as tauGFP-negative from their ear 
punch biopsies. The percentage of tauGFP-positive mice in the experimental cross (55.9%) was 
significantly below 75% (Table 1), suggesting that homozygotes do not survive until 3 weeks even 
if this frequency was also slightly underestimated. Furthermore, significantly more pups died 
between birth and weaning in the experimental than the control cross (Table 1) and death of 13.6% 
of the pups in the experimental cross was attributed to differences between the crosses. As this is 
less than the 25% expected, if all homozygotes died, some may die before birth or too soon after 
birth to be recorded.  
To investigate whether homozygous, TgTP6.4Tg/Tg E14.5 fetuses were viable, we compared 
observed and expected frequencies of tauGFP-positive fetuses in two crosses (Table 1). The control 
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and experimental crosses produced close to 50% and 75% tauGFP positive E14.5 fetuses 
respectively, as expected if all hemizygotes and homozygotes survived to E14.5. Survival of most 
homozygotes to E14.5 is also suggested by the relatively low frequency of dead embryos, which 
was not significantly elevated in the experimental cross. However, there was some evidence that 
homozygous tauGFP fetuses were slightly smaller than normal by E14.5. After allowing for 
variation among litters, tauGFP-positive fetuses in the experimental cross were significantly lighter 
than tauGFP-negative fetuses (P < 0.0001 by a 2-way ANOVA) and had shorter crown-rump 
lengths (P < 0.0001; Additional file 1: Fig. S2). In the control cross, fetal mass differences were 
less pronounced (P = 0.0343) and crown-rump length differences were not significant (P = 0.0597), 
implying that hemizygous TgTP6.4Tg/- fetuses were more normal in size at E14.5. In summary, the 
breeding experiments indicate that most TgTP6.4Tg/Tg homozygotes survive to E14.5 but some may 
already be retarded and they probably all die between E14.5 and weaning.  
TauGFP expression in TgTP6.4Tg/- preimplantation embryos  
To determine when the TgTP6.4 transgene was first expressed, preimplantation embryos produced 
by (C57BL × CBA/Ca)F1 females and hemizygous TgTP6.4Tg/- males were collected, cultured in an 
environmental chamber on the stage of an inverted confocal microscope (Additional file 1: Fig. S1) 
for up to 24 h. and imaged by time-lapse confocal microscopy to determine when tauGFP 
fluorescence became detectable. Fluorescence was not detected in embryos that were cultured from 
approximately 10 h. post coitum (p. c.) at the 1-cell stage (Fig. 2a) but it was detected in some 
embryos that were cultured from approximately 34 h. p.c. at the 2-cell stage (Fig. 2b,c). A plot of 
pixel intensities is shown in Fig. 2g for one group of embryos that were cultured from 34.5 h. (2-
cell stage) to 56.5 h. (4-cell stage). This confirmed that tauGFP expression was detectable in 
TgTP6.4Tg/- embryos at the 2-cell stage and fluorescence increased during the 24 h. culture period. 
There was considerable variation in pixel intensity among TgTP6.4Tg/- embryos but there was no 
overlap with the tauGFP-negative TgTP6.4-/- embryos from 38.3 h. p.c. A repeated measures 2-way 
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ANOVA with Bonferroni multiple comparison post-tests showed that pixel intensity first differed 
significantly between the two genotypes at 37.5 h. Although there were no significant differences 
before 37.5 h., some individual embryos that were subsequently identified as TgTP6.4Tg/- had higher 
pixel intensities than any TgTP6.4-/- embryos at the beginning of the experiment (34.5 h.). Some 
tauGFP-positive embryos were also identifiable visibly at this time (Fig. 2b) and differences 
probably reflect developmental heterogeneity. As the tauGFP fluorescence is detectable in 2-cell 
stage TgTP6.4Tg/- embryos by 37.5 h., and earlier in some embryos, the transgene will be expressed 
slightly before this age. 
Preimplantation embryos from the reciprocal cross between TgTP6.4Tg/- females and (C57BL × 
CBA/Ca)F1 males, initially all retained oocyte-encoded tauGFP but TgTP6.4Tg/- and TgTP6.4-/- 
embryos could be distinguished by their tauGFP levels by the 4-cell stage (Fig. 2d-f). There was no 
overlap in pixel intensity from 45 h. p.c. for the experiment shown in Fig. 2h and a repeated 
measures 2-way ANOVA with Bonferroni multiple comparison post-tests showed that pixel 
intensity differed significantly between the two genotypes from 42.5 h., consistent with the onset of 
embryo-coded TgTP6.4 expression by the late 2-cell stage. Comparisons of pixel intensity between 
TgTP6.4-/- embryos, with some residual tauGFP, and control WT embryos, with no tauGFP, showed 
no overlap in pixel intensity at any ages analysed (34.6 to 57.6 h.) and a repeated measures 2-way 
ANOVA with Bonferroni multiple comparison post-tests confirmed that pixel intensities remained 
significantly different at 57.6 h. This indicates that residual oocyte-encoded tauGFP remained at 
least until the 4-cell stage. 
TauGFP expression in fetal and adult TgTP6.4Tg/- tissues  
Confocal microscopy of E13.5 fetal heads showed that tauGFP fluorescence in the brain was 
weaker in TgTP6.4Tg/- than in TgTP6.3Tg/- hemizygotes (Fig. 3a,b) but the choroid plexus, which is 
rich in blood capillaries, fluoresced strongly (Fig. 3b), and other blood vessels in the TgTP6.4Tg/- 
fetal brain were also clearly delineated (Fig. 3c). In TgTP6.4Tg/- fetal eyes, most of the neural retina 
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showed little tauGFP fluorescence but the nerve fibre layer and inner nuclear layer of the neural 
retina fluoresced weakly and the retinal pigment epithelium, blood vessels and particularly the lens 
fluoresced strongly (Fig. 3d-f). Many other TgTP6.4Tg/- fetal tissues showed high levels of 
fluorescence including heart and lung (Fig. 3g,h). Much of the adult TgTP6.4Tg/- brain was 
characterised by poor tauGFP fluorescence, similar to fetal brain, although the Bergmann glia and 
blood vessels of the cerebellum fluoresced more strongly (Fig. 3i-k). Levels of tauGFP fluorescence 
varied among and within other adult TgTP6.4Tg/- organs. Like other blood vessels, the capillary 
knots of the kidney glomeruli fluoresced particularly strongly (Fig. 3l) and fluorescence was also 
readily detectable in lung, heart and liver (Fig. 3m-p). 
Fluorescence activated cell sorting (FACS) analysis of cell suspensions prepared from whole E14.5 
fetal brains confirmed that tauGFP fluorescence was present in fewer TgTP6.4Tg/- cells than 
TgTP6.3Tg/- cells (Fig. 3q-t). The analysis using three gated regions (Fig. 3q) is described in the 
Methods. Fig 3r shows that 95% of all the cells from whole TgTP6.3Tg/- brains were fluorescent 
(M1 gate in Fig. 3q), of which 87% were highly fluorescent (Fig. 3r). In contrast, only 25% of cells 
from whole TgTP6.4Tg/- brains were fluorescent, 10% of which were highly fluorescent (Fig. 3s). 
Nevertheless, this profile shows more fluorescence than the TgTP6.4-/- negative controls (Fig. 3t). 
Similar results were obtained for cells from separate brain regions although the hippocampus 
showed more fluorescence than other TgTP6.4Tg/- brain regions (Additional file 1: Table S1).  
The brain was not the only organ where TgTP6.4 expression appeared to be restricted to specific 
tissues or regions. While tauGFP fluorescence was detected in some ovarian cell types in adult 
TgTP6.4Tg/- females, no fluorescence was seen in ovarian follicle granulosa cells or oocytes (Fig. 
4a-c). Furthermore, although our initial survey of TgTP6.4Tg/- hemizygotes, on both predominantly 
C57BL/6 and outbred CD-1 backgrounds, showed that tauGFP was expressed relatively uniformly 
in most TgTP6.4Tg/- tissues, mosaic expression was increasingly common after several generations 
of crosses to (C57BL × CBA/Ca)F1 mice. Mosaicism affected all tissues examined, including the 
  16  
cornea, kidney, liver, heart and adrenal cortex (Fig. 4d-p). TgTP6.4Tg/- mice showing mosaic 
expression could be distinguished from those with uniform transgene expression by fluorescence 
microscopy of ear punch biopsies (Fig. 4q,r) and mice with a mosaic ear skin phenotype also 
showed mosaic expression in all internal organs examined. After several more generations, ear 
punch biopsies showed that all the TgTP6.4Tg/- mice in our colony had a mosaic expression pattern. 
In contrast, after crossing TgTP6.3Tg/- mice onto (C57BL × CBA/Ca)F1, we only detected mosaic 
expression in the cornea and adrenal cortex (Fig. 4s,t) and even this more restricted mosaicism only 
occurred in some mice. The TgTP6.3 transgene appeared to be uniformly expressed in other tissues, 
as previously reported [1, 2]. 
Comparison of mosaic tauGFP expression in TgTP6.3Tg/- and TgTP6.4Tg/- adrenal cortices  
The pattern of radial stripes seen in the adrenal cortex of some TgTP6.3Tg/- and TgTP6.4Tg/- mice 
(Fig. 4m-p,t) has been reported for several other experimental systems and is believed to represent 
coherent clones of cells, which are derived from stem cells at the periphery of the adrenal cortex, 
and move towards the medulla (see Discussion). After correcting for the expected number of 
multiple adjacent clones in a single stripe, the corrected stripe number can provide an indirect 
estimate of the number of clones of active stem cells as described elsewhere [15, 17, 18] so this can 
be used to compare stem cell function in different groups. The uncorrected mean stripe width varies 
with the percentage of tauGFP-positive cells in the adrenal cortex, which will affect the number of 
clones per stripe, but the corrected mean stripe width adjusts for this, as shown in Additional file 1: 
Fig. S3. The corrected mean stripe width was used to calculate a corrected stripe number, as 
explained in the Methods, to provide a quantitative comparison of TgTP6.3Tg/-and TgTP6.4Tg/- stripe 
patterns.  
We imaged vibratome sections of 60 adrenal glands, from 37 TgTP6.3Tg/- mice, 48 (80%) of which 
were mosaic (15 from 20 females and 33 from 40 males), and 31 adrenals, all of which were 
mosaic, from 20 TgTP6.4Tg/- mice (14 from 10 females and 17 from 10 males). Thus, at this stage, 
  17  
the frequency of adrenal mosaicism was high in both lines but it was significantly higher for 
TgTP6.4Tg/- (31/31 versus 48/60; P = 0.0069 by Fisher’s exact test). We analysed stripe patterns 
quantitatively for intact adrenal sections from mice that were at least 3 weeks old and grouped the 
results for one adrenal gland per mouse by genotype and sex. (After excluding adrenal glands from 
mice younger than three weeks, adrenal glands were analysed for 44 mice. Both adrenal glands 
were imaged for 18 mice but results were only included for one adrenal gland per mouse.) The mice 
differed widely in age but, as neither the percentage of tauGFP-positive cells nor the corrected 
mean stripe number differed significantly with age (Additional file 1: Fig. S4), we pooled results for 
different ages within each of the four groups (males and females in the two transgenic lines). The 
results (Fig. 5) showed that, as well as having a higher frequency of mosaic adrenals, TgTP6.4Tg/- 
mice had mosaic adrenals with a lower percentage of tauGFP-positive cells (means were 
approximately 38% versus 86%). However, the quantitative analysis of stripe patterns showed that 
the corrected stripe number was similar for both genotypes, regardless of sex. 
DISCUSSION 
The aim of the present study was to determine whether the TgTP6.4 marker transgene offered any 
advantages over TgTP6.3. Although tauGFP expression in TgTP6.3Tg/- cells provides an excellent 
marker, TgTP6.3Tg/Tg homozygotes do not survive and TgTP6.3Tg/- hemizygotes are slightly smaller 
than normal. TgTP6.4Tg/- growth was less affected than TgTP6.3Tg/- hemizygotes but TgTP6.4Tg/Tg 
homozygotes died between E14.5 and weaning age, as reported for TgTP6.3Tg/Tg homozygotes [2] 
and the widespread mosaicism means that TgTP6.4 is unsuitable as a conventional cell lineage 
marker. The reason why both TgTP6.3Tg/Tg and TgTP6.4Tg/Tg homozygotes die was not investigated 
but high levels of GFP or tau protein are neurotoxic [19]. Other tauGFP transgenic mice have been 
produced by inserting a tauGFP transgene into a specific locus [20-22] or randomly inserting a 
CAG-tauGFP construct into the genome to produce another CAG-tauGFP transgenic line [23], but 
no mosaic phenotypes were described for these mice. While mosaicism in TgTP6.3Tg/- mice was 
only identified in the cornea and adrenal cortex, mosaicism became increasingly common in 
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TgTP6.4Tg/- mice during our investigation and eventually affected all tissues examined and all 
TgTP6.4Tg/- mice.  
Mosaic patterns produced by mouse chimaeras and X-inactivation mosaics have been useful for 
visualising clonal lineages and for analysing the extent of cell mixing and movement during 
development, growth and maintenance of adult tissues [24-29]. Mosaic transgene expression can 
provide a useful alternative for these types of investigations [15], particularly when mosaicism is 
widespread, as in TgTP6.4Tg/- mice. We used this approach to investigate whether there were any 
overt differences in maintenance of the adrenal cortex in TgTP6.3Tg/- and TgTP6.4Tg/- adults. 
Mosaic TgTP6.3Tg/- and TgTP6.4Tg/- adrenals showed qualitatively similar radial stripes across the 
adrenal cortex. This pattern has previously been reported for other experimental systems, including 
mouse and rat chimaeras [24, 28, 30-33], mouse X-inactivation mosaics [33] and some other mouse 
lines that show mosaic transgene expression [15, 34-36]. The stripes are believed to represent 
coherent clones of cells that are derived from stem cells at the periphery of the adrenal cortex and 
they maintain the tissue as they move slowly across the cortex before undergoing apoptosis [15, 16, 
37-40]. The corrected stripe numbers were similar in the two genotypes and were comparable to 
results reported previously for mouse chimaeras, X-inactivation mosaics and other mosaic 
transgenic mice [15, 33], suggesting that maintenance of the adrenal cortex involved a similar 
number of active clones of stem cells in all these groups. 
Mosaic transgene expression is thought to involve position effect variegation caused by stochastic 
transgene silencing during development [34, 41-43]. Indirect evidence suggested that mosaic 
expression of a different transgene in the mouse adrenal cortex involved stochastic silencing at the 
level of the chromosome or transgene, rather than at the cellular level [44] but this may not apply to 
all mosaic transgenic lines. Transgene silencing can occur if the transgene integrates near an 
endogenous heterochromatic site [41], which may prevent the transcriptional machinery from 
accessing the transgene, or if it triggers the formation of heterochromatin by integrating as a series 
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of repeated copies [45, 46]. Repeat-copy transgenes are also associated with methylation changes 
that could mediate stochastic transgene silencing if transgene methylation levels vary among cells 
[47]. Moreover, several genes that alter the extent of transgene silencing have been identified in a 
mutagenesis screen and some have been characterised [48, 49]. However, the copy number is not 
known for either of the transgenic lines that we studied and the mechanism(s) that caused 
widespread mosaic silencing of TgTP6.4 and more restricted silencing of TgTP6.3 is unknown. 
TauGFP expression in TgTP6.3Tg/- preimplantation embryos was characterised previously [1, 2] and 
was similar in TgTP6.4Tg/- embryos. TauGFP fluorescence was ubiquitous in preimplantation 
embryos of both transgenic lines, so mosaic expression presumably involves transgene silencing in 
some cells during development. As there was no evidence for an age-effect on the percentage of 
cells expressing tauGFP in either TgTP6.3Tg/- or TgTP6.4Tg/- adrenals, we have no evidence that 
silencing is a continuous process. The simplest model assumes that transgene silencing involves a 
single stochastic event that occurs during development and the silent or active state is then stably 
inherited by daughter cells. As the frequency of TgTP6.4Tg/- mosaic expression changed over a 
number of generations of breeding and ultimately affected all tissues examined and the entire TP6.4 
colony, it seems likely that the genetic background somehow affects the probability of transgene 
silencing but, again, the mechanism remains unknown. 
In contrast to TgTP6.4Tg/- mice, mosaic expression did not occur in all TgTP6.3Tg/- mice, nor did it 
occur in so many tissues. Of the TgTP6.3Tg/- tissues examined, mosaicism was only identified in the 
adrenal cortex and cornea. Moreover, when mosaicism occurred in the adrenal cortex of TgTP6.3Tg/- 
mice, there were significantly more tauGFP-positive cells than in TgTP6.4Tg/- adrenals. This implies 
that silencing of the TgTP6.3 transgene affects fewer cells per tissue as well as fewer tissues and 
fewer mice. In both TgTP6.3Tg/- and TgTP6.4Tg/- mice, the mosaic pattern in the cornea was in the 
form of radial stripes, strongly suggesting it was in the corneal epithelium layer, as described for 
studies of the corneal epithelium using other mosaic systems [17, 18, 50-57].  
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Mosaicism in TgTP6.3Tg/- mice is clearly more restricted than in TgTP6.4Tg/- hemizygotes so it might 
arise later in development but this was not tested directly. Investigation of why the extent of 
mosaicism differs between these two transgenic lines would probably require breeding both 
transgenes onto the same inbred genetic background, as well as knowledge of the insertion sites, 
copy numbers and epigenetic modifications around the insertion sites. Stem cells at the tissue’s 
periphery are thought to maintain both the adult corneal epithelium [55-60] and the adrenal cortex 
[15, 16, 38-40]. It may also, therefore, be worth investigating whether transgene silencing can occur 
in tissue-specific stem cells as well as earlier in development. 
CONCLUSION 
Although widespread mosaic expression means that the TgTP6.4 transgene is not a suitable 
alternative to TgTP6.3 as a standard lineage marker, it provides a useful system for identifying and 
analysing clonal lineages. We exploited this mosaicism to demonstrate that similar clonal lineages 
maintained the adult adrenal cortex in different groups of mice. Differences, in the frequency and 
tissue distribution of mosaicism, between related transgenic lines, such as TP6.3 and TP6.4, may 
also provide a useful experimental system for investigating transgene silencing. 
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TABLE 
Table 1. Viability of TgTP6.4 hemizygotes and homozygotes assessed by frequencies of 
tauGFP-positive mice produced in different crosses. 
  
 Genetic cross (female ×  male)  
    
 Progeny Cross 1 Cross 2 Cross 3 
  (experimental cross) (control cross)   
  Tg/- ×  Tg/- Tg/- ×  -/- -/- ×  Tg/-  
  
A. Mice classified for tauGFP at ~ 3 weeks 
Total born 336 140 348  
Dead before weaning 52 (15.5%)a 3 (2.1%) 8 (2.3%)  
Dead after weaning (most unclassified) 5 (1.5%) 0 3 (0.9%)  
Viable at weaning 284 137 340  
TauGFP not classified 46 6 139  
TauGFP classified 238 131 201  
TauGFP-positive 133 (55.9%)b,c 57 (43.5%)d 79 (39.3%)e 
TauGFP-negative 105 (44.1%) 74 (56.5%) 122 (60.7%) 
Pre-weaning death attributable to cross† 13.6% NA NA 
B. Fetuses classified for tauGFP at E14.5 
Total conceptuses 193  192  
Moles (early deaths) 16 (8.3%)f 9 (4.7%)  
Dead fetuses 2 (1.0%)f 2 (1.0%)  
Total live fetuses 175 181  
TauGFP-positive 129 (73.7%)g,h 85 (47.0%)i  
TauGFP-negative 46 (26.3%) 96 (53.0%)  
Death attributable to cross†† 3.8% NA  
  
Abbreviations: -/-, non-transgenic TgTP6.4-/- was wild-type, (C57BL × CBA/Ca)F1; Tg/-, hemizygous 
TgTP6.4Tg/-; NA, not applicable. The percentage death, attributable to production of TgTP6.4Tg/Tg 
homozygotes in cross 1, was calculated by correcting for sporadic death in cross 2 [61]: 
† 
[1-( viable mice weaned in experimental cross 1 total born in experimental cross 1  / 
viable mice weaned in control cross 2 
total born in control cross 2 )]×100 
†† 
[1-( live fetuses in experimental cross 1 total conceptuses in experimental cross 1  / 
live fetuses in control cross 2 
total conceptuses in control cross 2 )]×100 
In (A), data were compiled retrospectively from breeding records and not all offspring were classified. Data 
were excluded if the whole litter died between birth and weaning or no offspring were classified. In later 
litters it was recorded that tauGFP expression was mosaic in ear tissue of some tauGFP-positive offspring. 
aThe frequency of death before weaning was significantly higher in cross 1 than cross 2 (P < 0.0001 by 
Fisher’s exact test). b-e The proportion of tauGFP-positive progeny in cross 1 differed significantly by 
goodness of fit chi-square test from 75% expected, if all homozygotes and hemizygotes are viable (P < 
0.0001)b, and from 67% expected, if all homozygotes die but all hemizygotes are viable (P = 0.0005)c. The 
proportion of tauGFP-positive progeny did not differ significantly from 50% expected in cross 2 (P = 0.1615 
by goodness of fit chi-square test)d but it did differ from this expected proportion in cross 3 (P = 0.003)e. f In 
(B), the frequencies of moles plus dead fetuses did not differ significantly between crosses 1 and 2 (P = 
0.2463 by Fisher’s exact test). g-i The proportion of tauGFP-positive fetuses in cross 1 did not differ 
significantly by goodness of fit chi-square test from either 75% expected, if all homozygotes and 
hemizygotes are viable (P = 0.7642)g or from 67% expected, if all homozygotes die but all hemizygotes are 
viable (P = 0.0578)h. In cross 2, the proportion of tauGFP-positive progeny did not differ significantly from 
50% expected (P = 0.4543 by goodness of fit chi-square test)i. 
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FIGURE LEGENDS 
Fig. 1. Growth of hemizygous tauGFP-positive and non-transgenic, tauGFP-negative 
littermates. Comparisons of postnatal body mass of hemizygous and non-transgenic (wild-type; 
WT) offspring from crosses between WT (C57BL × CBA/Ca)F1 females and hemizygous males: 
(a,b) GFP-positive (TgTP6.4Tg/-) and GFP-negative (WT, TgTP6.4-/-) females (a) and males (b). 
(c,d) GFP-positive (TgTP6.3Tg/-) and GFP-negative (WT, TgTP6.3-/-) females (c) and males (d). The 
numbers of mice are indicated above the graphs and error bars are 95% confidence intervals. 
Statistical significances by repeated measures 2-way ANOVA and Bonferroni multiple comparison 
post-tests are shown. Overall P-values are shown on the graphs and significant differences for 
comparisons between GFP-positive and GFP-negative progeny at each age are shown by asterisks: 
*P < 0.05; **P < 0.01; ***P < 0.001. Data for the TgTP6.3 crosses (c,d) were published previously 
[2] but were re-analysed for comparison with the TgTP6.4 crosses (a,b). 
Fig. 2. Expression of TgTP6.4 transgene in preimplantation embryos. (a-f) Transmitted light 
images with overlays from the confocal FITC channel to identify tauGFP in preimplantation 
embryos produced by crosses between WT, (C57BL × CBA/Ca)F1 females and hemizygous 
TgTP6.4Tg/- males (a-c) and in those produced by crosses between hemizygous TgTP6.4Tg/- females 
and (C57BL × CBA/Ca)F1 males (d-f). Images shown were captured during three separate time-
lapse, embryo culture experiments (shown in a, b-c and d-f respectively). Arrows in d-f indicate two 
(BALB/c × A/J)F2 negative control embryos and the embryo marked with the letter ‘x’ remained at 
the 2-cell stage throughout the culture period so was excluded from the quantitative study. The 
scale bar in a (for a-f) = 100 µm. (g,h) Plots of pixel intensity (produced by tauGFP fluorescence) at 
different times during embryo culture, time-lapse experiments for preimplantation embryos 
produced by crosses between (C57BL × CBA/Ca)F1 females and hemizygous TgTP6.4Tg/- males (g) 
and the reciprocal cross between hemizygous TgTP6.4Tg/- females and (C57BL × CBA/Ca)F1 males 
(h). The time-lapse experiments shown are representative of two such experiments for each cross. 
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Pixel intensity values for individual embryos are shown as points. Embryos were classified as 
TgTP6.4Tg/- or TgTP6.4-/- according to their pixel intensity at the end of the culture period and the 
mean value for each genotype is shown as a solid line (upper line is TgTP6.4Tg/-). In (h) pixel 
intensities are also shown for two (BALB/c × A/J)F2 negative control embryos (lowest line in h). 
The red arrows below the x-axis indicate times when the time-lapse was interrupted, sometimes 
causing differences in pixel intensity. A repeated measures 2-way ANOVA for (g) showed 
significant differences overall for age, genotype and interaction (P < 0.0001 in each case) and 
Bonferroni multiple comparison post-tests for each age showed that genotype differences were 
significant at 37.5 h. (P < 0.01), 38 h. (P < 0.05), and all times thereafter (P < 0.01 to P < 0.0001). 
For (h), a repeated measures 2-way ANOVA comparing embryos with high and low tauGFP levels 
showed significant differences overall for age, genotype and interaction (P < 0.0001 in each case) 
and Bonferroni multiple comparison post-tests for each age showed that genotype differences were 
significant from 42.5 h. (for 42.5-44.5 h., P < 0.05; for 45.0 to 47.4 h., P < 0.01 to P < 0.0001; from 
47.9 h., P < 0.0001). A repeated measures 2-way ANOVA comparing low tauGFP and (BALB/c × 
A/J)F2 negative control embryos showed significant differences overall for age (P = 0.0093) and 
genotype (P < 0.0001) but not the interaction (P = 0.1831) and Bonferroni multiple comparison 
post-tests for each age showed that genotype differences were significant at all ages (P < 0.05 to P 
< 0.0001) except for 38.5, 38.6 and 39.6 h. 
Fig. 3. TauGFP expression in fetal and adult tissues. (a-c) Confocal images of coronal vibratome 
sections of heads of E13.5 tauGFP-positive fetuses showing (a) TgTP6.3Tg/- head, (b) TgTP6.4Tg/- 
head with reduced levels of fluorescence in the brain and (c) higher magnification of part of 
TgTP6.4Tg/- forebrain showing strong tauGFP fluorescence in blood vessels but little or none in 
neural tissue. (d-f) Confocal images of vibratome sections of TgTP6.4Tg/- fetal eyes, showing (d) 
tauGFP fluorescence in the lens but not the neural retina at E17.5, (e) higher magnification view 
with little or no fluorescence in most of the E17.5 neural retina but weak fluorescence in the inner 
nuclear layer (INL) and nerve fibre layer (NFL) and strong fluorescence in the retinal pigment 
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epithelium (RPE) and (f) tauGFP fluorescence in the lens and hyaloid blood vessels but not the 
neural retina at E13.5. (g,h) Confocal images of E13.5, TgTP6.4Tg/- vibratome sections showing 
tauGFP fluorescence in (g) fetal heart and (h) fetal lung. (i-k) Confocal images of sagittal vibratome 
sections of adult TgTP6.4Tg/- brain showing (i) strong tauGFP fluorescence in the cerebellum but 
weaker fluorescence elsewhere, (j) tauGFP fluorescence and propidium iodide counterstain in the 
cerebellum and (k) higher magnification of tauGFP fluorescence in the cerebellum. (l-p) Confocal 
images of sagittal vibratome section of adult TgTP6.4Tg/- non-neural tissues showing tauGFP 
fluorescence in (l) kidney, with strongly-fluorescent glomeruli, (m) lung, (n,o) heart and (p) liver. 
(q-t) Histograms from FACS analysis of whole brains from E14.5 fetuses showing cell counts 
versus green fluorescence intensity (FL1-height). (q) Three gated regions defined from a 
TgTP6.3Tg/- tauGFP-positive sample are shown: M1 included all fluorescent cells, M2 included cells 
with low fluorescence (outside main fluorescent profile) and M3 included cells with high 
fluorescence (within main fluorescent profile). (r-t) FACS analysis showing the percentage of cells 
in each gated region for (r) tauGFP-positive TgTP6.3Tg/-, (s) tauGFP-positive TgTP6.4Tg/- and (t) 
tauGFP-negative TgTP6.4-/-, fetal brains. Abbreviations: BGCB, Bergmann glia cell body; BGCP, 
Bergmann glia cell processes; GCL, granule cell layer; INL, inner nuclear layer of neural retina; 
NFL, nerve fibre layer; RPE, retinal pigment epithelium. Scale bars: e,o = 50 µm; p = 100 µm; 
c,f,h,k,l = 200 µm; d,g,j,m,n = 500 µm; a,b,i = 1000 µm. 
Fig. 4. Non-ubiquitous and mosaic tauGFP expression. (a-c) Confocal images of vibratome 
section of adult tauGFP-positive TgTP6.4Tg/- ovary showing that the transgene is expression in some 
ovarian cell types but not in the follicular granulosa cells: (a) tauGFP fluorescence, (b) propidium 
iodide (PI) counterstain and (c) combined tauGFP and PI image. (d) Flat mount of TgTP6.4Tg/- 
cornea showing mosaic tauGFP expression. (e-p) Confocal images of vibratome sections of tauGFP 
fluorescence (e,g,i,k,m,o) and combined tauGFP fluorescence and PI counterstain (f,h,j,l,n,p), 
showing mosaic tauGFP expression in different TgTP6.4Tg/- tissues and organs: (e,f) kidney, (g,h) 
liver, (i-l) heart and (m-p) adrenal cortex. (q,r) Confocal images of whole mounts of ear punch 
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biopsies from TgTP6.4Tg/- mice showing (q) ubiquitous and (r) mosaic tauGFP expression. (s,t) 
Mosaic tauGFP expression in two TgTP6.3Tg/- tissues: (s) montage of flat mount of cornea and (t) 
vibratome section of adrenal cortex. Scale bars: e,f,g,h,k,l,o,p = 100 µm; a,b,c,q,r,t = 200 µm; 
i,j,m,n = 500 µm; d,s = 1000 µm. 
Fig. 5. Comparison of percentage of tauGFP-positive cells and corrected stripe number in 
mosaic adrenal cortices from four groups of tauGFP transgenic mice. (a) TgTP6.3Tg/- mosaic 
adrenal cortices had a higher mean percentage of tauGFP-positive cells than TgTP6.4Tg/- mosaic 
cortices and, for males, this was significant by Kruskal-Wallis (KW) tests and Dunn’s multiple 
comparison post-tests. There were no significant differences between males and females of the 
same genotype. The mean percentages of tauGFP-positive cells (±95% CI) were: TgTP6.3Tg/- 
females, 81.1±12.4%; TgTP6.4Tg/- females, 38.5±13.1%; TgTP6.3Tg/- males, 91.0±3.3%; TgTP6.4Tg/- 
males, 37.7±14.7%. (b) There were no significant differences in corrected stripe numbers in mosaic 
adrenal cortices among any of the four groups of mice (both sexes for two genotypes) by 2-way 
ANOVA and Bonferroni’s multiple comparison post-tests. The mean corrected stripe numbers 
(±95% CI) were: TgTP6.3Tg/- females, 44.1±12.8; TgTP6.4Tg/- females, 50.8±9.5; TgTP6.3Tg/- males, 
60.5±12.2; TgTP6.4Tg/- males, 57.0±7.2. The box and whisker plots show the median (horizontal 
line within the box), upper and lower quartiles (top and bottom of boxes), and the minimum and 
maximum of all the data (ends of whiskers). ***P < 0.001. The number of adrenal glands in each 
group is shown within or above the box and whiskers; one adrenal gland was analysed per mouse. 
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ADDITIONAL FILE 
 
Figure S1. Confocal microscope with environmental chamber. (a) The Leica DMIRB/E inverted 
confocal microscope is shown together with the stage-mounted environmental chamber and some of 
the equipment required to maintain the correct temperature and gas phase within the chamber. (b) 
Side view of the environmental chamber with a culture dish on the heated stage. The flow of carbon 
dioxide from the gas cylinder to the environmental chamber was controlled by an infrared gas 
monitor to ensure that the gas mixture inside the environmental chamber was maintained at 5% CO2 
in air. Embryos were cultured in drops of culture medium under liquid paraffin oil in a WillCo thin 
glass-bottomed culture dish on the heated stage. Time-lapse images of the embryos were acquired 
every 15 or 30 minutes in both fluorescent (FITC) and transmitted light modes for up to 24 hours. 
Abbreviations: EC, environmental chamber; GC, gas cylinder; GM, gas monitor; HS, heated stage; 
HSC, heated stage controller. 
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Figure S2. Comparison of sizes of E14.5 tauGFP-positive and tauGFP-negative fetuses from 
two crosses. (a-d) Comparisons of tauGFP-positive and tauGFP-negative fetal sizes using a 2-way 
analysis of variance (ANOVA) to allow for variation among litters. The graphs show fetal mass (a) 
and crown-rump length (b) for the TgTP6.4Tg/- female × TgTP6.4Tg/- male cross plus fetal mass (c) 
and crown-rump length (d) for the TgTP6.4Tg/- female × TgTP6.4-/- male cross. Each point 
represents a single fetus and fetuses are arranged by litters. Sexes were not distinguished and only 
litters with both tauGFP-positive and tauGFP-negative fetuses were included. Numbers of fetuses, 
means and P-values are shown. (e-h) Differences between within-litter means are shown for fetal 
mass and crown-rump length for tauGFP-positive and tauGFP-negative fetuses in each cross. P-
values are shown for paired t-tests. Abbreviations: GFP-ve, tauGFP-negative; GFP+ve, tauGFP-
positive. 
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Figure S3. Relationship between mean stripe width and the percentage of tauGFP-positive 
cells in TgTP6.4Tg/- adrenal cortices. (a) The uncorrected mean tauGFP-positive stripe width for 
27 TgTP6.4Tg/- adrenal glands varied widely. It was close to 2% of the adrenal circumference when 
the percentage of tauGFP-positive cells in the adrenal cortex was low but it was positively 
correlated with the percentage of tauGFP-positive cells. The Spearman correlation coefficient (rs) is 
shown. This positive correlation is likely to be because stripes may comprise several adjacent 
coherent clones of cells and the average number of tauGFP-positive clones per tauGFP-positive 
stripe will increase with the percentage of tauGFP-positive cells in the adrenal cortex. (b) The 
corrected mean tauGFP-positive stripe width was not significantly correlated with the percentage of 
tauGFP-positive cells so allows comparisons among adrenals with different percentages of tauGFP-
positive cells. The observed (uncorrected) mean tauGFP-positive stripe number was corrected by 
dividing it by the correction factor 1/(1-p), where p is the proportion of tauGFP-positive cells 
around the circumference as explained in the Methods.   
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Figure S4. Age has no effect on percentage of tauGFP-positive cells or corrected stripe 
number in mosaic adrenal cortices of TgTP6.3Tg/- and TgTP6.4Tg/- mice. (a-d) There were no 
significant differences among age groups for the % tauGFP-positive cells in the adrenal cortex for 
(a) TgTP6.3Tg/- females (b) TgTP6.3Tg/- males (c) TgTP6.4Tg/- females or (d) TgTP6.4Tg/- males. Mice 
were grouped into three or more age groups and analysed by the Kruskal-Wallis test (KW test). (e-
h) There were also no significant positive correlations between age and the % tauGFP-positive cells 
in the adrenal cortex for any of the four groups. Spearman correlation coefficients (rs) are shown. (i-
l) There were no significant differences among age groups for the corrected stripe number (tauGFP-
positive stripes plus tauGFP-negative stripes) in the adrenal cortex for any sex and genotype 
combination. Mice were grouped into three or more age groups and analysed by the Kruskal-Wallis 
test (KW test) or 1-way ANOVA. (m-p) There were also no significant positive correlations 
between age and the corrected stripe number in the adrenal cortex for any sex and genotype 
combination. Pearson correlation coefficients (r) and the linear regression lines are shown but no 
lines differed significantly from horizontal. N = number of adrenal glands; one adrenal gland was 
analysed per mouse. 
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Table S1. FACS analysis of fetal brains 
  
Sample  Percentage of cells in  Ratio of M2 : M3 cells*  
 fluorescent region M1*   
  Percentage M2   Percentage M3  
  (low fluorescence) (high fluorescence) 
  
GFP-positive TgTP6.3Tg/- 
Whole brain 95.26 13.37 86.63 
Hippocampus 95.90 11.75 88.25  
Cerebral cortex 98.52 11.69 88.31  
Ventral telencephalon 96.29 24.17 75.83  
Central and dorsal thalamus 92.99 8.72 91.28  
Mid brain and hind brain 94.79 23.72 76.28  
GFP-negative TgTP6.3-/- 
Whole brain 0.55 98.18 1.82 
 
GFP-positive TgTP6.4Tg/- 
Whole brain 25.26 89.78 10.22 
Hippocampus 52.84 87.12 12.88  
Cerebral cortex 39.34 91.34 8.66  
Ventral telencephalon 26.53 88.90 11.10   
Central and dorsal thalamus 43.27 88.93 11.07 
Mid brain and hind brain 40.23 88.05 11.95  
GFP-negative TgTP6.4-/- 
Whole brain 0.65 86.36 13.64 
  
* Three gated regions were defined from a tauGFP-positive, TgTP6.3Tg/- sample. Region M1 
included all fluorescent cells, M2 included cells with low fluorescence and M3 included cells with 
high fluorescence.  
 
